Minims Fenylefrinehydrochloride Bausch + Lomb Ireland Limited (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Minims Fenylefrinehydrochloride Bausch + Lomb Ireland Limited, is an alpha‑adrenergic agonist presented as an ocular solution for eye use. It reduces ocular redness by constricting conjunctival blood vessels and is available over the counter for adult patients. GNH USA supplies Minims Fenylefrinehydrochloride Bausch + Lomb Ireland Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Phenylephrine Hydrochloride acts on the ocular vasculature to relieve redness and hyperemia. - Redness of the eye: diminishes visible redness by vasoconstriction of conjunctival vessels. - Ocular hyperemia: reduces excessive blood flow causing a pink eye appearance. - Conjunctival irritation: alleviates mild irritation‑related redness without affecting vision.

Phenylephrine Hydrochloride may cause local ocular reactions, although many users experience no adverse events.

Common Side Effects: - Stinging or burning sensation: transient discomfort upon instillation. - Mild eye irritation: temporary feeling of grittiness. - Temporary blurred vision: short‑lived visual disturbance. - Tearing: increased lacrimation after use. - Headache: mild headache in sensitive individuals.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Elevated intra‑ocular pressure: possible in glaucoma patients. - Persistent redness: worsening of ocular redness. - Severe eye pain: intense discomfort requiring medical review. - Vision loss: rare but urgent ophthalmic emergency.

Before using Phenylephrine Hydrochloride, consider the following precautions. - Contraindication: avoid in patients with known hypersensitivity to phenylephrine or any formulation component. - Glaucoma: use with caution in individuals with narrow‑angle or uncontrolled glaucoma. - Systemic absorption: limit use to recommended frequency to reduce systemic adrenergic effects. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Pediatric use: not recommended for children without medical advice. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Phenylephrine Hydrochloride can interact with other agents that affect adrenergic pathways.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other ocular decongestants: additive vasoconstriction may increase ocular pressure.

Moderate Interactions (Monitor Closely):\n- Systemic sympathomimetics (e.g., pseudoephedrine): may enhance systemic adrenergic effects. - Antihypertensive medications: potential reduction in blood pressure control. - Anticholinergic eye drops: possible alteration of ocular surface dynamics.